Induction and latency (J-F Boivin, March 2006)

46
Induction and latency (J-F Boivin, March 2006) 1. Introduction 2. Rothman’s model of induction 3. Analysis: largest estimate methods 4. Modelling approaches Thomas 1983 Rachet et al. 2003 Version: 22 February 2006

description

Induction and latency (J-F Boivin, March 2006). Introduction Rothman’s model of induction Analysis: largest estimate methods Modelling approaches Thomas 1983 Rachet et al. 2003. Version: 22 February 2006. - PowerPoint PPT Presentation

Transcript of Induction and latency (J-F Boivin, March 2006)

Page 1: Induction and latency (J-F Boivin, March 2006)

Induction and latency(J-F Boivin, March 2006)

1. Introduction2. Rothman’s model of induction3. Analysis: largest estimate

methods4. Modelling approaches

• Thomas 1983• Rachet et al. 2003

Version: 22 February 2006

Page 2: Induction and latency (J-F Boivin, March 2006)

19-year-old woman developed nausea, vomiting, salivation, and sweating soon after breakfast, and she was taken to a local hospital. She had a cardiorespiratory arrest but was successfully resuscitated. It was found that she had ingested the pesticide fonofos mistakenly used as flour in making the pancakes cooked for breakfast. Three other members of her family who ate the pancakes were also very sick and one died.

At age 39, the woman developed a cancer of the liver and died.

Page 3: Induction and latency (J-F Boivin, March 2006)

Causal inferences usually proceed without difficulty when cause and effect are close in time. When the interval between cause and effect is lengthy, however, the linkage between the two is more difficult to infer.

(adapted from Rothman, 1981)

Page 4: Induction and latency (J-F Boivin, March 2006)

Rothman KJ.

Induction and latent periods.

American Journal of Epidemiology 1981

Page 5: Induction and latency (J-F Boivin, March 2006)

Point exposures

• Atomic bombs• Food toxins• In utero exposures• Earthquake• Surgery• Vaccine

Page 6: Induction and latency (J-F Boivin, March 2006)

Point exposure, fixed induction period

Exposure

Diseaseinitiation

Diseasedetection

Induction period

Diseases have several component causes, genetic and environmental: the complete induction period begins at conception of the fetusMore useful to characterize induction periods in reference to specific component causes

Induction period is not a fixed characteristic of the disease; varies according to component cause investigated

Page 7: Induction and latency (J-F Boivin, March 2006)

Point exposure, fixed induction period

Exposure

Diseaseinitiation

Diseasedetection

For any disease, at least one component cause, the last, will have a very short (zero) induction period

Induction

remaining component causesin the etiologic sequence contribute to the causal process

Page 8: Induction and latency (J-F Boivin, March 2006)

Point exposure, fixed induction period

Exposure

Diseaseinitiation

Diseasedetection

Latent period(= incubation)

= Interval after disease initiation until disease is detected

Could, in principle, be reduced to near zero with increasingly accurate means for detecting presymptomatic disease

Page 9: Induction and latency (J-F Boivin, March 2006)

Point exposure, fixed induction period

Exposure

Diseaseinitiation

Diseasedetection

Latent period

Example: if cancer, once it reaches a certain critical point, is irreversible without therapy, it has a latent period that is distinct from the induction period

Counter-example: if some infectious process can in principle be overcome by the host’s defenses until it becomes clinically manifest, there is no latent period

Page 10: Induction and latency (J-F Boivin, March 2006)

Point exposure, fixed induction period

Diseaseinitiation

Diseasedetection

Latent period

In practice, induction and latent period can rarely bebe separated

Induction period

Empirical induction period

Exposure

Page 11: Induction and latency (J-F Boivin, March 2006)

Point exposure, variable induction period

Exposure Disease detection

12 yr 17 yr

Empirical induction period (12 to 17 yr)

Page 12: Induction and latency (J-F Boivin, March 2006)

Excessincidence

0

Page 13: Induction and latency (J-F Boivin, March 2006)

Incidence

Time

Exposed Unexposed

Page 14: Induction and latency (J-F Boivin, March 2006)

Analysis

Two simultaneous goals:

1. Estimate the mode of the distribution of empirical induction periods

2. Estimate the effect of the exposure on disease risk without bias due to inappropriate assumption about induction period

Page 15: Induction and latency (J-F Boivin, March 2006)

Principle

Measures of effect are reduced if an inappropriate assumption is used for the empirical induction period

(nondifferential misclassification)

Page 16: Induction and latency (J-F Boivin, March 2006)

RR No

exposureIn utero

DES

1 1/10 000 1/10 0000–9 yr

11/10 000 1/10 00010–19 yr

10001/10 0001 000/10 00020–29 yr

3343/30 0001 002/30 000all yr

Page 17: Induction and latency (J-F Boivin, March 2006)

• Estimate the measure of association repeatedly with different assumptions about the induction period

• The maximum point estimate of the measure of association corresponds to the most appropriate assumption about induction period and simultaneously offers an estimate of the maximum effect relatively unobscured by an inappropriate assumption

Page 18: Induction and latency (J-F Boivin, March 2006)

Limitation of largest estimate methods(Rothman-Greenland 1998, pp. 298-299)

1. Tend to pick out induction periods

whose estimate is large simply by virtue

of large statistical variability

2. Exposure misclassification may vary

over time, leading to distortions of

patterns of effect estimates across time

windows

Page 19: Induction and latency (J-F Boivin, March 2006)

Example of inconsistent results using single time windows

Richardson DB, Wing S.

International Journal of Epidemiology 1999

Page 20: Induction and latency (J-F Boivin, March 2006)
Page 21: Induction and latency (J-F Boivin, March 2006)
Page 22: Induction and latency (J-F Boivin, March 2006)
Page 23: Induction and latency (J-F Boivin, March 2006)

3. Some exposure effects may have long and variable induction times. Separate analyses of restricted time windows do not control for effects in other time windows. Such multiple effects would often lead to mutual confounding among the estimates using just one window at a time.

Limitation of largest estimate methods(Rothman-Greenland 1998, pp. 298-299)

(several point exposures)

Page 24: Induction and latency (J-F Boivin, March 2006)

Alternative approach

Estimate the effects for each time window while adjusting for the exposures from

other windows

Sharpe et al. British Journal of Cancer 2002

Page 25: Induction and latency (J-F Boivin, March 2006)
Page 26: Induction and latency (J-F Boivin, March 2006)
Page 27: Induction and latency (J-F Boivin, March 2006)

Multiple time-windows approach

Problem: numbers

Page 28: Induction and latency (J-F Boivin, March 2006)

Modelling

Thomas 1983

Page 29: Induction and latency (J-F Boivin, March 2006)

(RE-R0) (T) = b T

0

d(t) f (T-t)

excess risk up to time T

Page 30: Induction and latency (J-F Boivin, March 2006)

excess risk caused byunit dose

(RE-R0) (T) = b T

0

d(t) f (T-t)

Page 31: Induction and latency (J-F Boivin, March 2006)

dose

dose at time t

“weight” of the dose at time t

(RE-R0) (T) = b T

0

d(t) f (T-t)

Page 32: Induction and latency (J-F Boivin, March 2006)

excess risk =excess risk per unit dose

weighteddose

(RE-R0) (T) = b T

0

d(t) f (T-t)

Page 33: Induction and latency (J-F Boivin, March 2006)

• Some functional form is assumed:

• Rothman’s approach (AJE 1981):

weight is between times a and b

at other times

1

0

DES example

f = 1 between ages 20 and 29

f = 0 at other times

a and b determined by trial and error

(RE-R0) (T) = b T

0

d(t) f (T-t)

Page 34: Induction and latency (J-F Boivin, March 2006)

E-

E+

0 10 20 30 yr

10/10,000

10/10,000

55/10,000

10/10,000

100/10,000

10/10,000

RE-R0 0 45/10,000 90/10,000

Page 35: Induction and latency (J-F Boivin, March 2006)

E+

E-

0 10 20 30

165/30,000 = 55/10,000

30/30,000 = 10/10,000

RE-R0 = 45/10,000RE-R0 = (45/10,000) x 1

Page 36: Induction and latency (J-F Boivin, March 2006)

E+

E-

10/10,000

10/10,000

RE-R0 = 0 67.5/10,000 RE-R0 = (67.5/10,000) x 0

+ (67.5/10,000) x 1

155/20,000 = 77.5/10,000

20/20,000 = 10/10,000

Page 37: Induction and latency (J-F Boivin, March 2006)

E-

E+ 10/10,000

10/10,000

55/10,000

10/10,000

100/10,000

10/10,000

RE-R0 0 45/10,000 90/10,000

RE-R0 = (90/10,000) x 0

+ (90/10,000) x 0.5

+ (90/10,000) x 1

Page 38: Induction and latency (J-F Boivin, March 2006)

Lundin et al. (1979)

Lung cancer in uranium miners

f: assumed to be log normal (based on leukemiarisk after single exposure to radiation and anincubation period for infectious diseases)

Values of 5, 10, 15 yr for induction period are fitted

Standard deviation of 0.17609 log t units is assumed

ER (T) = bT

0

d(t) f (T-t) dt

Page 39: Induction and latency (J-F Boivin, March 2006)

Complexities of modelling

• Relevant exposure may be a complex function of the intensity of the exposure and time (Rothman-Greenland, p. 83)

• Influence of intensity

• Influence of age at exposure atomic bomb survivors

Page 40: Induction and latency (J-F Boivin, March 2006)
Page 41: Induction and latency (J-F Boivin, March 2006)

Rachet et al.

Statistics in Medicine 2003

Page 42: Induction and latency (J-F Boivin, March 2006)

Limitation of Thomas’ approach

Requires selecting a limited set of a priori parametric models for change in risks, such as the log-normal, piecewise constant, bilinear, etc. However, discriminating between alternative parametric models may be difficult.

Page 43: Induction and latency (J-F Boivin, March 2006)

Rachet et al.

• no strong a priori assumptions

• however: dichotomous point

exposure

Page 44: Induction and latency (J-F Boivin, March 2006)

Rachet et al.

Overall hazard ratio (HR) represents

weighted average of

• HR1 = 1

• HR2 > 1

Page 45: Induction and latency (J-F Boivin, March 2006)

ReferencesLand CE, Tokunaja M. Induction period. In: Boice JD Jr, Faumeni JF

Jr, eds. Radiation carcinogenesis. Epidemiology and biological significance. Progress in cancer research and therapy. Volume 26. New York: Raven Press. 1984. Pages 421-436.

Lundin FE, et al. An exposure-time-response model for lung cancer mortality in uranium miners: Effects of radiation exposure, age, and cigarette smoking. In: Energy and health. Breslow NE, Whittermore AS, eds. Philadelphia: Society for industrial and applied mathematics. 1979.

Rachet B, et al. Estimating the distribution of lag in the effect of short-term exposures and interventions: adaptation of a non-parametric regression spline model. Statistics in Medicine 2003; 22: 2335-2363.

Richardson DB, Wing S. Greater sensitivity to ionizing radiation at older age: follow-up of workers at Oak Ridge National Laboratory through 1990. International Journal of Epidemiology 1999; 28: 428-436.

Page 46: Induction and latency (J-F Boivin, March 2006)

Rothman KJ. Induction and latent periods. American Journal of Epidemiology 1981; 114:253-259.

Rothman KJ, Greenland S. Modern epidemiology. Second edition. Pages 14, 15, 82-84, 297-300.

Thomas DC. Statistical methods for analyzing effects of temporal patterns of exposure on cancer risks. Scandinavian Journal of Work and Environmental Health 1983; 9:353-366.

Thomas DC. Models for exposure time-response relationships with applications to cancer epidemiology. Annual Reviews of Public Health 1988; 9:451-482.

Sharpe CR, et al. The effects of tricyclic antidepressants on breast cancer risk. British Journal of Cancer 2002; 86: 92-97.